Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients

Br J Haematol. 2007 May;137(3):268-9. doi: 10.1111/j.1365-2141.2007.06538.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols*
  • Cyclophosphamide / administration & dosage
  • Dexamethasone / administration & dosage
  • Humans
  • Lenalidomide
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Retrospective Studies
  • Thalidomide / administration & dosage
  • Thalidomide / analogs & derivatives
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Dexamethasone
  • Cyclophosphamide
  • Lenalidomide